Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab in Chronic Low Back Pain with Modic Changes
NCT03704363Phase 3Completed
- Sponsor
- Oslo University Hospital
- Start
- Dec 2018
- Primary completion
- Jul 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of infliximab in chronic low back pain (CLBP), sponsored by Oslo University Hospital. Started Dec 2018; status: completed.
02
Drugs
infliximab
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT03704363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03704363.